LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

McKesson Corp

Slēgts

SektorsVeselības aprūpe

915.02 -1.68

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

913.76

Max

921.19

Galvenie mērījumi

By Trading Economics

Ienākumi

40M

1.3B

Pārdošana

3B

106B

P/E

Sektora vidējais

28.574

66.845

Dividenžu ienesīgums

0.31

Peļņas marža

1.177

Darbinieki

43,000

EBITDA

374M

1.8B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+8.47% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.31%

2.25%

Nākamie ieņēmumi

2026. g. 7. maijs

Nākamais dividenžu datums

2026. g. 1. apr.

Nākamais Ex dividenžu datums

2026. g. 1. jūn.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

17B

122B

Iepriekšējā atvēršanas cena

916.7

Iepriekšējā slēgšanas cena

915.02

Ziņu noskaņojums

By Acuity

39%

61%

82 / 351 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

McKesson Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. marts 19:32 UTC

Iegādes, apvienošanās, pārņemšana

Diana Shipping Increases Offer to Acquire Genco -- Update

2026. g. 6. marts 17:44 UTC

Iegādes, apvienošanās, pārņemšana

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

2026. g. 7. marts 02:30 UTC

Galvenie ziņu notikumi

Iran War Is Kicking India When It's Already Down -- Barrons.com

2026. g. 6. marts 22:26 UTC

Galvenie ziņu notikumi

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

2026. g. 6. marts 22:07 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

2026. g. 6. marts 21:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 6. marts 21:37 UTC

Peļņas

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

2026. g. 6. marts 21:25 UTC

Galvenie ziņu notikumi

How The Iran War Impacts Ukraine. -- Barrons.com

2026. g. 6. marts 21:17 UTC

Peļņas

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

2026. g. 6. marts 20:50 UTC

Peļņas

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

2026. g. 6. marts 20:46 UTC

Peļņas

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026. g. 6. marts 20:31 UTC

Galvenie ziņu notikumi

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

2026. g. 6. marts 20:18 UTC

Tirgus saruna

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

2026. g. 6. marts 20:12 UTC

Tirgus saruna
Galvenie ziņu notikumi

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

2026. g. 6. marts 19:10 UTC

Tirgus saruna
Galvenie ziņu notikumi

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

2026. g. 6. marts 18:54 UTC

Tirgus saruna

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

2026. g. 6. marts 18:44 UTC

Tirgus saruna
Galvenie ziņu notikumi

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

2026. g. 6. marts 18:08 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 17:49 UTC

Tirgus saruna

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

2026. g. 6. marts 17:46 UTC

Galvenie ziņu notikumi

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

2026. g. 6. marts 17:40 UTC

Tirgus saruna
Peļņas

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

2026. g. 6. marts 17:40 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 17:32 UTC

Tirgus saruna
Galvenie ziņu notikumi

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

2026. g. 6. marts 17:28 UTC

Tirgus saruna
Galvenie ziņu notikumi

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna
Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

McKesson Corp Prognoze

Cenas mērķis

By TipRanks

8.47% augšup

Prognoze 12 mēnešiem

Vidējais 997.1 USD  8.47%

Augstākais 1,107 USD

Zemākais 885 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi McKesson Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

11 ratings

9

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

681.92 / 707.28Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

No Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

82 / 351 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat